Table 3 Changes in BP measurements.
D&E group | Control group | ANOVA p-value for time*group interaction | ANOVA p-value for group effect at week 12 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Baseline | Week 12 | Δ | ANOVA p-value for time effect | Baseline | Week 12 | Δ | ANOVA p-value for time effect | |||
24-hour SBP (mmHg) | 134.4 ± 9 | 135.5 ± 9 | 1.1 | 0.712 | 131.6 ± 7 | 134.4 ± 13 | 2.8 | 0.339 | 0.667 | 0.796 |
24-hour DBP (mmHg) | 85.9 ± 10 | 84.4 ± 13 | -1.5 | 0.626 | 83.4 ± 7 | 84.3 ± 8 | 0.9 | 0.515 | 0.421 | 0.996 |
24-hour daytime SBP (mmHg) | 136.8 ± 9 | 136.8 ± 10 | 0.0 | 0.443 | 133.9 ± 7 | 135.9 ± 13 | 2.0 | 0.408 | 0.461 | 0.876 |
24-hour daytime DBP (mmHg) | 87.9 ± 11 | 87.3 ± 10 | -0.6 | 0.893 | 85.3 ± 8 | 85.7 ± 9 | 0.4 | 0.447 | 0.651 | 0.673 |
24-hour nighttime SBP (mmHg) | 127.1 ± 12 | 129.7 ± 11 | 2.8 | 0.349 | 125.0 ± 9 | 128.0 ± 16 | 3.0 | 0.770 | 0.654 | 0.612 |
24-hour nighttime DBP (mmHg) | 79.7 ± 10 | 81.5 ± 9 | 1.8 | 0.242 | 77.9 ± 8 | 79.2 ± 7 | 1.3 | 0.545 | 0.697 | 0.320 |
Office SBP (mmHg) | 141.4 ± 7 | 132.0 ± 10 | -9.4 | < 0.001 | 138.9 ± 7 | 144.7 ± 16 | 5.8 | 0.035 | 0.003 | 0.012 |
Office DBP (mmHg) | 87.4 ± 9 | 82.1 ± 11 | -5.3 | 0.086 | 84.7 ± 7 | 87.7 ± 10 | 3.0 | 0.088 | 0.017 | 0.099 |
Central SBP (mmHg) | 151.1 ± 17 | 146.2 ± 20 | -4.9 | 0.127 | 144.8 ± 18 | 145.0 ± 19 | 0.2 | 0.924 | 0.150 | 0.888 |
Augmentation index | 83.6 ± 19 | 82.0 ± 16 | -1.6 | 0.284 | 78.2 ± 14 | 77.1 ± 16 | -1.1 | 0.486 | 0.214 | 0.262 |
PWV (cm/s) | 1609.8 ± 247 | 1610.2 ± 332 | 0.4 | 0.146 | 1516.9 ± 248 | 1528.8 ± 336 | 11.9 | 0.520 | 0.340 | 0.477 |
